Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(S)-3-(4-HYDROXYPHENYL)-2-HYDROXYPROPIONIC ACID, commonly known as caffeic acid, is a naturally occurring organic compound found in a variety of plant sources. It is a hydroxycinnamic acid that falls within the phenolic group of compounds, characterized by its potent antioxidant properties. Caffeic acid has demonstrated anti-inflammatory and neuroprotective effects, and it is also being studied for its potential anti-cancer properties. Widely present in dietary sources such as coffee, fruits, vegetables, and wine, it is recognized for its health-promoting benefits due to its antioxidant capacity and other potential therapeutic effects.

23508-35-2

Post Buying Request

23508-35-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

23508-35-2 Usage

Uses

Used in Pharmaceutical Industry:
Caffeic acid is utilized as a therapeutic agent for its anti-inflammatory and neuroprotective properties, making it a candidate for the treatment of various inflammatory and neurodegenerative conditions. Its antioxidant capabilities also contribute to its potential use in preventing or mitigating oxidative stress-related diseases.
Used in Cancer Research and Treatment:
Caffeic acid is employed as a potential anti-cancer agent, with ongoing research exploring its effects on different types of cancer. Its ability to modulate cellular processes and exhibit anti-proliferative activity suggests its use in cancer prevention and treatment strategies.
Used in Functional Foods and Nutraceuticals:
Recognized for its beneficial dietary properties, caffeic acid is used as a functional ingredient in foods and nutraceutical products. Its incorporation aims to enhance the health benefits of these products, capitalizing on its antioxidant and anti-inflammatory effects to promote overall wellness.
Used in Cosmetics:
Leveraging its antioxidant properties, caffeic acid is used in the cosmetics industry for its potential to protect the skin from oxidative damage, reduce inflammation, and potentially slow down the aging process, making it a valuable component in skincare formulations.
Used in Agricultural Applications:
In agriculture, caffeic acid may be used for its natural antioxidant properties to enhance the shelf life of fruits and vegetables, protecting them from post-harvest degradation and maintaining their nutritional value.

Check Digit Verification of cas no

The CAS Registry Mumber 23508-35-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,3,5,0 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 23508-35:
(7*2)+(6*3)+(5*5)+(4*0)+(3*8)+(2*3)+(1*5)=92
92 % 10 = 2
So 23508-35-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8,10-11H,5H2,(H,12,13)/t8-/m0/s1

23508-35-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2-hydroxy-3-(4-hydroxyphenyl)propanoic acid

1.2 Other means of identification

Product number -
Other names (S)-3-(4-Hydroxyphenyl)-2-hydroxypropionic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:23508-35-2 SDS

23508-35-2Synthetic route

4-Hydroxyphenylpyruvic acid
156-39-8

4-Hydroxyphenylpyruvic acid

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With triethylamine; B-chlorodiisopinocampheylborane In tetrahydrofuran92%
With triethylamine; B-chlorodiisopinocampheylborane In tetrahydrofuran at -30℃; optical yield given as %ee;78%
Stage #1: 4-hydroxyphenylpiruvic acid With triethylamine In N,N-dimethyl-formamide at -40℃; for 0.166667h;
Stage #2: With B-chlorodiisopinocampheylborane In tetrahydrofuran; N,N-dimethyl-formamide at -20 - 20℃; for 12.5h; enantioselective reaction;
71%
(S)-3-(4-hydroxy-phenyl)-2-methoxy-propionic acid sodium salt

(S)-3-(4-hydroxy-phenyl)-2-methoxy-propionic acid sodium salt

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With hydrogenchloride; sodium iodide at 110℃; for 24h;91%
(S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid
343880-41-1

(S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid
33173-34-1

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid

Conditions
ConditionsYield
With boron tribromide In dichloromethane at -10℃;A 7%
B 90%
(S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid
343880-41-1

(S)-2-ethoxy-3-(4-methoxyphenyl)propanoic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid
325793-65-5

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid

Conditions
ConditionsYield
With hydrogen iodide In waterA 10%
B 80%
L-tyrosine
60-18-4

L-tyrosine

A

4-Hydroxyphenylpyruvic acid
156-39-8

4-Hydroxyphenylpyruvic acid

B

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With formate dehydrogenase; oxygen; ammonium formate; NADH In aq. phosphate buffer at 21℃; under 750.075 Torr; for 7h; pH=7; Concentration; Enzymatic reaction; stereoselective reaction;A 2 %Chromat.
B 80%
(S)-3-(4-(benzyloxy)phenyl)-2-hydroxypropanoic acid
162919-37-1

(S)-3-(4-(benzyloxy)phenyl)-2-hydroxypropanoic acid

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With hydrogen; 10 percent Pd/C In methanol; ethyl acetate for 20h; atmospheric pressure;70%
tyrosine
556-02-5

tyrosine

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

L-tyrosine
60-18-4

L-tyrosine

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With nitric acid
durch Einwirkung von Bacillus subtilis in Gegenwart von Phosphaten;
With bacterium subtilis
With barium nitrite; sulfuric acid
4-amino-L-phenylalanine
943-80-6

4-amino-L-phenylalanine

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With hydrogenchloride; sodium nitrite 1.) 0 deg C, overnight, 2.) reflux, 15 min; Yield given. Multistep reaction;
4-Hydroxyphenylpyruvic acid
156-39-8

4-Hydroxyphenylpyruvic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(R)-3-(4-hydroxyphenyl)lactic acid
89919-57-3

(R)-3-(4-hydroxyphenyl)lactic acid

Conditions
ConditionsYield
With triethylamine; B-chlorodiisopinocampheylborane In tetrahydrofuran 1.) -20 deg C, 5 min; 2.) 20 deg C, then 0 deg C, 3 h; Yield given; Yields of byproduct given. Title compound not separated from byproducts;
With triethylamine; B-chlorodiisopinocampheylborane In tetrahydrofuran Title compound not separated from byproducts;
With C20H34BCl; triethylamine In tetrahydrofuran at 20℃; for 12h; Overall yield = 70 percent; Overall yield = 299 mg;A n/a
B n/a
inactive form

inactive form

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With water; MORPHIN
methyl 2-dihydroxy-3-(4-methoxyphenyl)propanoate
856899-98-4

methyl 2-dihydroxy-3-(4-methoxyphenyl)propanoate

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
With sodium hydroxide In ethanol for 3h;
4-methoxy-benzaldehyde
123-11-5

4-methoxy-benzaldehyde

indenyl magnesium bromide

indenyl magnesium bromide

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1.2: Microbiological reaction
2.1: 100 percent / H2 / Pd/C / ethyl acetate / 16 h / 20 °C / 2327.17 Torr
3.1: aq. NaOH / ethanol / 3 h
View Scheme
(2S,3R)-methyl p-methoxycinnamate epoxide
137173-40-1

(2S,3R)-methyl p-methoxycinnamate epoxide

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 100 percent / H2 / Pd/C / ethyl acetate / 16 h / 20 °C / 2327.17 Torr
2: aq. NaOH / ethanol / 3 h
View Scheme
(S)-2-acetoxy-3-(4-(benzyloxy)phenyl)propanoic acid
267228-34-2

(S)-2-acetoxy-3-(4-(benzyloxy)phenyl)propanoic acid

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 99 percent / 0.1 mol/l LiOH / tetrahydrofuran / 20 h / 20 °C
2: 70 percent / H2 / 10 percent Pd/C / ethyl acetate; methanol / 20 h / atmospheric pressure
View Scheme
ethyl 2-ethoxy-3-(4-methoxyphenyl)-2-propenoate

ethyl 2-ethoxy-3-(4-methoxyphenyl)-2-propenoate

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid
325793-65-5

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sodium hydroxide; ethanol / toluene
2: hydrogen; 5%-palladium/activated carbon / Isopropyl acetate / 3 h / 22 - 25 °C / 3000.3 Torr / Autoclave; Inert atmosphere
3: Isopropyl acetate / 0.17 h / 45 - 47 °C
4: hydrogen iodide / water
View Scheme
ethyl 2-ethoxy-3-(4-methoxyphenyl)-2-propenoate

ethyl 2-ethoxy-3-(4-methoxyphenyl)-2-propenoate

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid
33173-34-1

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: sodium hydroxide; ethanol / toluene
2: hydrogen; 5%-palladium/activated carbon / Isopropyl acetate / 3 h / 22 - 25 °C / 3000.3 Torr / Autoclave; Inert atmosphere
3: Isopropyl acetate / 0.17 h / 45 - 47 °C
4: boron tribromide / dichloromethane / -10 °C
View Scheme
(Z)-2-ethoxy-3-(4-methoxyphenyl)propenoic acid
1214260-73-7

(Z)-2-ethoxy-3-(4-methoxyphenyl)propenoic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid
325793-65-5

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogen; 5%-palladium/activated carbon / Isopropyl acetate / 3 h / 22 - 25 °C / 3000.3 Torr / Autoclave; Inert atmosphere
2: Isopropyl acetate / 0.17 h / 45 - 47 °C
3: hydrogen iodide / water
View Scheme
(Z)-2-ethoxy-3-(4-methoxyphenyl)propenoic acid
1214260-73-7

(Z)-2-ethoxy-3-(4-methoxyphenyl)propenoic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid
33173-34-1

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogen; 5%-palladium/activated carbon / Isopropyl acetate / 3 h / 22 - 25 °C / 3000.3 Torr / Autoclave; Inert atmosphere
2: Isopropyl acetate / 0.17 h / 45 - 47 °C
3: boron tribromide / dichloromethane / -10 °C
View Scheme
2-ethoxy-3-(4-methoxyphenyl)propanoic acid

2-ethoxy-3-(4-methoxyphenyl)propanoic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid
325793-65-5

(2S)-2-Ethoxy-3-(4-hydroxyphenyl)propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Isopropyl acetate / 0.17 h / 45 - 47 °C
2: hydrogen iodide / water
View Scheme
2-ethoxy-3-(4-methoxyphenyl)propanoic acid

2-ethoxy-3-(4-methoxyphenyl)propanoic acid

A

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

B

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid
33173-34-1

(S)-2-hydroxy-3-(4-methoxyphenyl)propanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Isopropyl acetate / 0.17 h / 45 - 47 °C
2: boron tribromide / dichloromethane / -10 °C
View Scheme
methanol
67-56-1

methanol

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

(S)-3-(4-hydroxyphenyl)-2-hydroxypropionyl methyl ester
123359-33-1

(S)-3-(4-hydroxyphenyl)-2-hydroxypropionyl methyl ester

Conditions
ConditionsYield
With hydrogenchloride at 20℃; for 2h;100%
1-Decanol
112-30-1

1-Decanol

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

C19H30O4

C19H30O4

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;95%
1-dodecyl alcohol
112-53-8

1-dodecyl alcohol

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

C21H34O4

C21H34O4

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;91%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

acetic anhydride
108-24-7

acetic anhydride

C13H14O6

C13H14O6

Conditions
ConditionsYield
With pyridine at 20℃; for 3h;90%
With pyridine
With dmap; triethylamine In dichloromethane at 21℃; for 3h;
With dmap In ethyl acetate at 30℃; for 1h;
3-(5-bromopentoxy)-estra-1,3,5(10)-triene-17β-ol
22034-75-9

3-(5-bromopentoxy)-estra-1,3,5(10)-triene-17β-ol

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

C32H42O6

C32H42O6

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;84%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

butan-1-ol
71-36-3

butan-1-ol

(S)-latifolicinin A

(S)-latifolicinin A

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;82%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

N,0-dimethylhydroxylamine
1117-97-1

N,0-dimethylhydroxylamine

(S)-2-hydroxy-3-(4-hydroxyphenyl)-N-methoxy-N-methylpropanamide
915396-55-3

(S)-2-hydroxy-3-(4-hydroxyphenyl)-N-methoxy-N-methylpropanamide

Conditions
ConditionsYield
Stage #1: N,0-dimethylhydroxylamine With 4-methyl-morpholine In dichloromethane at 0℃; for 0.0833333h;
Stage #2: (S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid With dmap; dicyclohexyl-carbodiimide In dichloromethane at 0 - 20℃; for 14.0833h; chemoselective reaction;
79%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

hexan-1-ol
111-27-3

hexan-1-ol

C15H22O4

C15H22O4

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;69%
ethanol
64-17-5

ethanol

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

latifolicinin B
267228-41-1

latifolicinin B

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;66%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

1-chloro-3,7-dimethylocta-2,6-diene
5389-87-7

1-chloro-3,7-dimethylocta-2,6-diene

C19H26O4

C19H26O4

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;64%
octanol
111-87-5

octanol

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

C17H26O4

C17H26O4

Conditions
ConditionsYield
With sulfuric acid at 80℃; for 2h;64%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

C24H34O4

C24H34O4

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 8h;42%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

methyl N2-(((R)-2-amino-4-phenylbutanoyl)-D-prolyl)-Nω-nitro-D-argininate

methyl N2-(((R)-2-amino-4-phenylbutanoyl)-D-prolyl)-Nω-nitro-D-argininate

methyl N2-(((2R)-2-((S)-2-hydroxy-3-(4-hydroxyphenyl)propanamido)-4-phenylbutanoyl)-L-prolyl)-Nω-nitro-D-argininate

methyl N2-(((2R)-2-((S)-2-hydroxy-3-(4-hydroxyphenyl)propanamido)-4-phenylbutanoyl)-L-prolyl)-Nω-nitro-D-argininate

Conditions
ConditionsYield
With 4-methyl-morpholine; O‐(1H‐benzotriazol‐1‐yl)‐N,N,N′,N′‐tetramethyluronium tetrafluoroborate In N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere;31%
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

urea
57-13-6

urea

oidium lactis

oidium lactis

4-Hydroxyphenylpyruvic acid
156-39-8

4-Hydroxyphenylpyruvic acid

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

(R)-3-(4-hydroxyphenyl)lactic acid
89919-57-3

(R)-3-(4-hydroxyphenyl)lactic acid

Conditions
ConditionsYield
With BIS-TRIS buffer; Lactobacillus halotolerans DSM 20190 In water at 42℃; for 24h; pH=6;
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

benzyl chloride
100-44-7

benzyl chloride

(S)-3-(4-Benzyloxy-phenyl)-2-hydroxy-propionic acid benzyl ester

(S)-3-(4-Benzyloxy-phenyl)-2-hydroxy-propionic acid benzyl ester

Conditions
ConditionsYield
With potassium carbonate In ethanol for 24h; Heating;
With potassium carbonate In ethanol for 18h;
(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid
23508-35-2

(S)-2-hydroxy-3-(4-hydroxy-phenyl)-propionic acid

4-(3-chloropropoxy)-O-phenylphenol
179020-04-3

4-(3-chloropropoxy)-O-phenylphenol

(S)-2-Hydroxy-3-{4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid
945292-58-0

(S)-2-Hydroxy-3-{4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid

Conditions
ConditionsYield
With sodium hydroxide In dimethyl sulfoxide for 3h; Heating;

23508-35-2Relevant articles and documents

Aeruginosins 102-A and B, new thrombin inhibitors from the cyanobacterium Microcystis viridis (NIES-102)

Matsuda, Hisashi,Okino, Tatsufumi,Murakami, Masahiro,Yamaguchi, Katsumi

, p. 14501 - 14506 (1996)

Aeruginosins 102-A and B were isolated from the freshwater cyanobacterium Microcystis aeruginosa (NIES-102). Their structures were elucidated to be 1 and 2 on the basis of 2D NMR data and chemical degradation. These peptides inhibited thrombin potently.

A Phenylpyruvic Acid Reductase Is Required for Biosynthesis of Tropane Alkaloids

Qiu, Fei,Yang, Chunxian,Yuan, Lina,Xiang, Dan,Lan, Xiaozhong,Chen, Min,Liao, Zhihua

, p. 7807 - 7810 (2018)

Solanaceous medicinal plants produce tropane alkaloids (TAs). We discovered a novel gene from Atropa belladonna, AbPPAR, which encodes a phenylpyruvic acid reductase required for TA biosynthesis. AbPPAR was specifically expressed in root pericycles and endodermis. AbPPAR was shown to catalyze reduction of phenylpyruvic acid to phenyllactic acid, a precursor of TAs. Suppression of AbPPAR disrupted TA biosynthesis through reduction of phenyllactic acid levels. In summary, we identified a novel enzyme involved in TA biosynthesis.

Synthesis of Weinreb amides using diboronic acid anhydride-catalyzed dehydrative amidation of carboxylic acids

Shimada, Naoyuki,Takahashi, Naoya,Ohse, Naoki,Koshizuka, Masayoshi,Makino, Kazuishi

supporting information, p. 13145 - 13148 (2020/11/09)

The first successful example of the direct synthesis of Weinreb amides using catalytic hydroxy-directed dehydrative amidation of carboxylic acids using the diboronic acid anhydride catalyst is described. The methodology is applicable to the concise syntheses of eight α-hydroxyketone natural products, namely, sattabacin, 4-hydroxy sattabacin, kurasoins A and B, soraphinols A and B, and circumcins B and C.

Mechanistic study of the radical SAM-dependent amine dehydrogenation reactions

Ji, Xinjian,Liu, Wan-Qiu,Yuan, Shuguang,Yin, Yue,Ding, Wei,Zhang, Qi

, p. 10555 - 10558 (2016/09/02)

The radical SAM enzyme NosL catalyzes the conversion of l-Trp to 3-methyl-2-indolic acid, and this reaction is initiated by the 5′-deoxyadenosyl (dAdo) radical-mediated hydrogen abstraction from the l-Trp amino group. We demonstrate here that when d-Trp was used in the NosL reaction, hydrogen abstraction occurs promiscuously at both the amino group and Cα of d-Trp. These results inspired us to establish the detailed mechanism of l-Trp amine dehydrogenation catalyzed by a NosL mutant, and to engineer a novel radical SAM-dependent l-Tyr amine dehydrogenase from the thiamine biosynthesis enzyme ThiH.

Latifolicinin A from a Fermented Soymilk Product and the Structure-Activity Relationship of Synthetic Analogues as Inhibitors of Breast Cancer Cell Growth

Ke, Yi-Yu,Tsai, Chen-Hsuan,Yu, Hui-Ming,Jao, Yu-Chen,Fang, Jim-Min,Wong, Chi-Huey

, p. 9715 - 9721 (2015/11/24)

The functional components in soymilk may vary depending upon the fermentation process. A fermented soymilk product (FSP) obtained by incubation with the microorganisms of intestinal microflora was found to reduce the risk of breast cancer. Guided by the inhibitory activities against breast cancer cells, two cytotoxic compounds, daidzein and (S)-latifolicinin A, were isolated from the FSP by repetitive extraction and chromatography. Latifolicinin A is the n-butyl ester of β-(4-hydroxyphenyl)lactic acid (HPLA). A series of the ester and amide derivatives of (S)-HPLA and l-tyrosine were synthesized for evaluation of their cytotoxic activities. In comparison, (S)-HPLA derivatives exhibited equal or superior inhibitory activities to their l-tyrosine counterparts, and (S)-HPLA amides showed better cytotoxic activities than their corresponding esters. In particular, (S)-HPLA farnesyl amide was active to triple-negative MDA-MB-231 breast cancer cells (IC50 = 27 μM) and 10-fold less toxic to Detroit-551 normal cells.

Biocontrolled formal inversion or retention of L -α-amino acids to enantiopure (R)- or (S)-hydroxyacids

Busto, Eduardo,Grischek, Barbara,Kroutil, Wolfgang,Richter, Nina

supporting information, p. 11225 - 11228,4 (2015/01/07)

Natural L-α-amino acids and L-norleucine were transformed to the corresponding α-hydroxy acids by formal biocatalytic inversion or retention of absolute configuration. The one-pot transformation was achieved by a concurrent oxidation reduction cascade in aqueous media. A representative panel of enantiopure (R)- and (S)-2-hydroxy acids possessing aliphatic, aromatic and heteroaromatic moieties were isolated in high yield (67-85 %) and enantiopure form (>99 % ee) without requiring chromatographic purification.

Concise, protecting group free total syntheses of (+)-sattabacin and (+)-4-hydroxysattabacin

Aronoff, Matthew R.,Bourjaily, Neil A.,Miller, Kenneth A.

scheme or table, p. 6375 - 6377 (2011/01/03)

The first asymmetric total syntheses of the antiviral natural products (+)-sattabacin and (+)-4-hydroxysattabacin are reported. Both total syntheses are remarkably concise and were completed without the use of protecting groups. These syntheses allowed the unambiguous assignment of the absolute configuration of both natural products. The syntheses of these natural products, which exhibit marked antiviral activity, are readily amenable to the preparation of structural analogs and progress in this regard is also reported.

4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARα/γ agonists. Part I: Synthesis and pharmacological evaluation

Parmenon, Cecile,Guillard, Jerome,Caignard, Daniel-Henri,Hennuyer, Nathalie,Staels, Bart,Audinot-Bouchez, Valerie,Boutin, Jean-Albert,Dacquet, Catherine,Ktorza, Alain,Viaud-Massuard, Marie-Claude

, p. 1617 - 1622 (2008/09/19)

Type-2 diabetes (T2D) is a complex metabolic disease characterized by insulin resistance in the liver and peripheral tissues accompanied by a defect in pancreatic β-cell. Since their discovery three subtypes of Peroxisomes Proliferators Activated Receptors were identified namely PPARα, PPARγ and PPARβ/(δ). We were interested in designing novel PPARγ selective agonists and/or dual PPARα/γ agonists. Based on the typical topology of synthetic PPAR agonists, we focused our design approach on 4,4-dimethyl-1,2,3,4-tetrahydroquinoline as novel cyclic tail.

METHOD FOR SYNTHESIS OF KETO ACID OR AMINO ACID BY HYDRATION OF ACETHYLENE COMPOUND

-

Page/Page column 24, (2008/12/06)

An object of the present invention is to provide a method for synthesis of keto acids by hydration of an acetylene compound (acetylene-carboxylic acids) under mild conditions free from harmful mercury catalysts and a method for synthesis of amino acids from acetylene-carboxylic acids in a single container (one-pot or tandem synthesis). In one embodiment of the method according to the present invention for synthesis of keto acids, acetylene-carboxylic acids is hydrated in the presence of a metal salt represented by General Formula (1), where M1 represents an element in Group VIII, IX, or X of the periodic table, and X1, X2, or X3 ligand represents halogen, H2O, or a solvent molecule, and k represents a valence of a cation species, and Y represents an anion species, and L represents a valence of the anion species, and each of K and L independently represents 1 or 2, and k × m = L × n.

An asymmetric synthesis of PPAR-γ agonist navaglitazar from (+)-methyl (2S,3R)-3-(4-methoxyphenyl)glycidate

Rizzo, John R.,Zhang, Tony Y.

, p. 580 - 583 (2007/10/03)

An asymmetric synthesis of navaglitazar, a peroxisome proliferator activated receptor (PPAR) γ agonist, from commercially available (+)-methyl (2S,3R)-3-(4-methoxyphenyl)glycidate, is described. The new synthesis features high overall yield, low solvent usage, crystalline intermediates and operational simplicity. Schweizerische Chemische Gesellschaft.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 23508-35-2